stockrow
Friday 6 November 2026
Export OPCH’s income statement to Excel — free account
Option Care Health, Inc.
OPCH Healthcare Medical Care Facilities
Option Care Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.6 billion, up 13.0% from fiscal 2024.
- Revenue
- +4.08%
- EPS
- +19.8%
- Free cash flow
- −17.0%
- Total debt
- −0.93%
Quarter to September 2026, against a year earlier
31.52
0.13
−0.41%
Follow OPCH
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
24.89 | 20.87 | 15.77 | 16.14 |
P/S ratio |
0.91 | 0.74 | 0.56 | 0.59 | |
P/FCF ratio |
23.78 | 19.84 | 10.55 | 11.96 | |
P/Operating CF |
143.89 | (348.23) | 17.47 | 29.36 | |
P/B ratio |
3.89 | 3.12 | 2.55 | 2.67 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.08 | 0.92 | 0.73 | 0.74 | |
EV/EBITDA |
14.76 | 12.84 | 10.22 | 10.35 | |
EV/Operating CF |
23.57 | 20.51 | 12.03 | 13.12 | |
EV/FCF |
28.06 | 24.46 | 13.73 | 15.01 | |
Quick Ratio |
0.85 | 0.95 | 0.86 | 0.95 | |
Current Ratio |
1.53 | 1.64 | 1.47 | 1.54 | |
Net Debt/EBITDA |
8.25 | 11.05 | 9.26 | 0.00 | |
Debt/Assets |
33.59% | 34.31% | 34.30% | 33.11% | |
Debt/Equity |
0.88 | 0.86 | 0.92 | 0.87 | |
Asset Turnover |
1.64 | 1.69 | 1.68 | 1.65 | |
Operating CF/Net income |
0.61 | (0.27) | 3.41 | 2.00 | |
Capex/Depreciation |
(0.65) | (0.55) | (0.58) | (0.38) | |
Interest Coverage |
7.19 | 5.45 | 6.07 | 6.93 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
11.75% | 12.92% | 11.42% | 11.52% | |
Intangible Assets out of Total Assets |
0.47 | 0.48 | 0.48 | 0.47 | |
Share Based Compensation of Revenue |
0.64% | 0.76% | 0.58% | 0.00% | |
Graham Net Nets |
(0.17) | (0.20) | (0.29) | (0.25) | |
Graham Number |
15.35 | 15.82 | 15.70 | 0.00 | |
Earnings Yield |
4.02% | 4.79% | 6.34% | 6.20% | |
Free Cash Flow Yield |
4.20% | 5.04% | 9.47% | 8.36% | |
Revenue per Share |
9.04 | 8.62 | 9.43 | 9.97 | |
Operating CF per Share |
0.22 | (0.08) | 1.20 | 0.77 | |
Capex per Share |
(0.08) | (0.06) | (0.07) | (0.04) | |
Free Cash Flow per Share |
0.14 | (0.14) | 1.13 | 0.72 | |
Cash per Share |
1.44 | 1.13 | 1.27 | 2.00 | |
Shareholders Equity per Share |
8.18 | 8.62 | 8.24 | 8.84 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
8.18 | 8.62 | 8.24 | 8.84 | |
Free Cash Flow |
22.25 | (21.16) | 172.52 | 108.05 | |
Working Capital |
435.62 | 465.36 | 381.12 | 461.56 | |
Capital Expenditures |
(13.65) | (9.05) | (11.08) | (6.68) | |
Net Current Asset Value |
(864.41) | (833.92) | (918.29) | (839.70) | |
EV/EBIT |
18.03 | 15.70 | 12.50 | 12.49 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.00 | |
Price to Operating Income |
15.28 | 12.73 | 9.61 | 9.95 | |
| Other line items | |||||
Average Receivables |
441.65 | 496.54 | 496.38 | 490.03 | |
Average Payables |
625.30 | 536.93 | 614.99 | 649.27 | |
Average Inventory |
429.64 | 392.36 | 401.57 | 411.88 | |
Average Assets |
3,438.76 | 3,344.31 | 3,380.80 | 3,478.06 | |
Average Common Equity |
1,365.32 | 1,350.95 | 1,309.92 | 1,341.57 |
Columns are period end dates · fundamentals updated 5 Nov 2026